AAAAAA

   
Results: 1-10 |
Results: 10
Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint
Authors: Wise, R Andrews, JM Ashby, JP
Citation: R. Wise et al., Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint, J ANTIMICRO, 48(4), 2001, pp. 563-567
Pharmacokinetics and tissue penetration of gemifloxacin following a singleoral dose
Authors: Gee, T Andrews, JM Ashby, JP Marshall, G Wise, R
Citation: T. Gee et al., Pharmacokinetics and tissue penetration of gemifloxacin following a singleoral dose, J ANTIMICRO, 47(4), 2001, pp. 431-434
The in vitro activity of ABT773, a new ketolide antimicrobial agent
Authors: Andrews, JM Weller, TMA Ashby, JP Walker, RM Wise, R
Citation: Jm. Andrews et al., The in vitro activity of ABT773, a new ketolide antimicrobial agent, J ANTIMICRO, 46(6), 2000, pp. 1017-1022
Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria
Authors: Andrews, JM Ashby, JP Jevons, GM Wise, R
Citation: Jm. Andrews et al., Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria, J ANTIMICRO, 44(6), 1999, pp. 819-822
A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose
Authors: Wise, R Andrews, JM Ashby, JP Marshall, J
Citation: R. Wise et al., A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose, J ANTIMICRO, 44(5), 1999, pp. 701-704
Study to assess the reliability of a disc diffusion method for determiningthe sensitivity of Gram-positive pathogens to dalfopristin/quinupristin
Authors: Andrews, JM Ashby, JP Wise, R
Citation: Jm. Andrews et al., Study to assess the reliability of a disc diffusion method for determiningthe sensitivity of Gram-positive pathogens to dalfopristin/quinupristin, J ANTIMICRO, 43(1), 1999, pp. 141-143
Amniotic fluid levels of dimeric inhibins, pro-alpha C inhibin, activin A and follistatin in Down's syndrome
Authors: Wallace, EM D'Antona, D Shearing, C Evans, LW Thirunavukarasu, P Ashby, JP Shade, M Groome, NP
Citation: Em. Wallace et al., Amniotic fluid levels of dimeric inhibins, pro-alpha C inhibin, activin A and follistatin in Down's syndrome, CLIN ENDOCR, 50(5), 1999, pp. 669-673
Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies
Authors: Blundell, G Ashby, JP Martin, C Shearing, CH Langdale-Brown, B Keeling, J Ellis, PM Shade, M Chambers, SE Wenham, PR
Citation: G. Blundell et al., Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies, PRENAT DIAG, 19(3), 1999, pp. 219-223
The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent
Authors: Boswell, FJ Andrews, JM Ashby, JP Fogarty, C Brenwald, NP Wise, R
Citation: Fj. Boswell et al., The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent, J ANTIMICRO, 42(6), 1998, pp. 703-709
The in-vitro activity of linezolid (U-100766) and tentative breakpoints
Authors: Wise, R Andrews, JM Boswell, FJ Ashby, JP
Citation: R. Wise et al., The in-vitro activity of linezolid (U-100766) and tentative breakpoints, J ANTIMICRO, 42(6), 1998, pp. 721-728
Risultati: 1-10 |